| Year |
Citation |
Score |
| 2019 |
Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. e13718. PMID 31498961 DOI: 10.1111/Nmo.13718 |
0.335 |
|
| 2018 |
Ingles PP, Peoker A, Robles A, Sarosiek J, McCallum R, Sarosiek I, Schmulson M, Bashashati M. Mucosal Mast Cells Are Increased in the Small Intestine of Patients With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis American Journal of Gastroenterology. 113: S261-S262. DOI: 10.14309/00000434-201810001-00449 |
0.328 |
|
| 2017 |
Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, et al. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. PMID 28851005 DOI: 10.1111/Nmo.13192 |
0.49 |
|
| 2017 |
Bashashati M, Fichna J, Piscitelli F, Capasso R, Izzo AA, Sibaev A, Timmermans JP, Cenac N, Vergnolle N, Di Marzo V, Storr M. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29. PMID 28695708 DOI: 10.1111/Nmo.13148 |
0.311 |
|
| 2017 |
Zielińska M, Fichna J, Bashashati M, Habibi S, Sibaev A, Timmermans JP, Storr M. G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29. PMID 28191706 DOI: 10.1111/Nmo.13025 |
0.326 |
|
| 2015 |
Bashashati M, Nasser Y, Keenan CM, Ho W, Piscitelli F, Nalli M, Mackie K, Storr MA, Di Marzo V, Sharkey KA. Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. British Journal of Pharmacology. 172: 3099-111. PMID 25684407 DOI: 10.1111/Bph.13114 |
0.641 |
|
| 2015 |
Bashashati M, Habibi HR, Keshavarzian A, Schmulson M, Sharkey KA. Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Current Drug Targets. 16: 199-208. PMID 25601328 DOI: 10.2174/1389450116666150120104012 |
0.526 |
|
| 2015 |
Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. British Journal of Pharmacology. 172: 2406-18. PMID 25572435 DOI: 10.1111/Bph.13069 |
0.492 |
|
| 2015 |
Bashashati M, Rezaei N, Quigley EM, Schmulson MJ, Sharkey KA. Mo2042 TNFα in Irritable Bowel Syndrome (IBS): From Gene Polymorphisms to Circulating Levels Gastroenterology. 148: S-777. DOI: 10.1016/S0016-5085(15)32651-2 |
0.476 |
|
| 2015 |
Bashashati M, Keenan CM, Burkhardt W, Hermanson DJ, Kingsley PJ, Patel S, Marnett L, Sharkey KA. 386 Endocannabinoid-Mediated Effects of Substrate-Selective COX-2 Inhibitors on Gastrointestinal Motility in the Mouse Gastroenterology. 148: S-80. DOI: 10.1016/S0016-5085(15)30280-8 |
0.493 |
|
| 2014 |
Bashashati M, Rezaei N, Shafieyoun A, McKernan DP, Chang L, Öhman L, Quigley EM, Schmulson M, Sharkey KA, Simrén M. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 26: 1036-48. PMID 24796536 DOI: 10.1111/Nmo.12358 |
0.507 |
|
| 2014 |
Nasser Y, Bashashati M, Andrews CN. Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher". Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 26: 447-54. PMID 24641009 DOI: 10.1111/Nmo.12329 |
0.592 |
|
| 2014 |
Bashashati M, McCallum RW. Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders. European Journal of Pharmacology. 722: 79-94. PMID 24161560 DOI: 10.1016/J.Ejphar.2013.09.075 |
0.327 |
|
| 2014 |
Bashashati M, Ho W, Mackie K, Hollenberg MD, Sharkey KA. Sa2055 Alpha/Beta Hydrolase Domain 6 (ABHD6), A Novel Endocannabinoid Hydrolytic Enzyme, Regulates Contractility in the Mouse Intestine Gastroenterology. 146: S-365. DOI: 10.1016/S0016-5085(14)61322-6 |
0.457 |
|
| 2013 |
Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li Y, Zimmer A, Göke B, Sharkey KA, Storr M. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology. 71: 255-63. PMID 23603203 DOI: 10.1016/J.Neuropharm.2013.03.029 |
0.559 |
|
| 2013 |
Fichna J, Habibi S, Bashashati M, Storr M. Mo2098 A Novel Function for Estrogen Receptor GPR30: Control of Gastrointestinal Motility and Visceral Sensation Gastroenterology. 144: S-741-S-742. DOI: 10.1016/S0016-5085(13)62750-X |
0.312 |
|
| 2013 |
Bashashati M, Rezaei N, Shafieyoun A, Samii L, Sharkey KA. Mo2034 Reduced Expression of Colonic Mucosal IL-10 mRNA in Irritable Bowel Syndrome: A Meta-Analysis Gastroenterology. 144: S-723. DOI: 10.1016/S0016-5085(13)62686-4 |
0.491 |
|
| 2012 |
Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: 1102-e566. PMID 22897390 DOI: 10.1111/J.1365-2982.2012.01990.X |
0.491 |
|
| 2012 |
Martin GR, Alvarez AL, Bashashati M, Keenan CM, Jirik FR, Sharkey KA. Endogenous cellular prion protein regulates contractility of the mouse ileum. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: e412-24. PMID 22762267 DOI: 10.1111/J.1365-2982.2012.01970.X |
0.652 |
|
| 2012 |
Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA, Muruve DA, McKay DM, Beck PL, Mawe GM, Thompson RJ, Sharkey KA. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nature Medicine. 18: 600-4. PMID 22426419 DOI: 10.1038/Nm.2679 |
0.675 |
|
| 2012 |
Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, Storr MA. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 57: 201-9. PMID 22178716 DOI: 10.1016/J.Cyto.2011.11.019 |
0.525 |
|
| 2012 |
Bashashati M, Storr MA, Nikas SP, Wood JT, Godlewski G, Liu J, Ho W, Keenan CM, Zhang H, Alapafuja SO, Cravatt BF, Lutz B, Mackie K, Kunos G, Patel KD, et al. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. British Journal of Pharmacology. 165: 1556-71. PMID 21883147 DOI: 10.1111/J.1476-5381.2011.01644.X |
0.662 |
|
| 2012 |
Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Tu1427 Interleukin-10 and TGF-1 Anti-Inflammatory Cytokine Gene Polymorphisms are Involved in the Pathophysiology of Irritable Bowel Syndrome: A Meta-Analysis Gastroenterology. 142: S-830. DOI: 10.1016/S0016-5085(12)63221-1 |
0.499 |
|
| 2012 |
Gulbransen BD, Bashashati M, Hirota SA, Roberts JA, Beck PL, MacDonald JA, Muruve D, McKay DM, Mawe GM, Thompson RJ, Sharkey KA. 635 Activating Neuronal P2X7-Pannexin−1 Mediates Inflammation-Induced Enteric Neuron Death Gastroenterology. 142: S-126. DOI: 10.1016/S0016-5085(12)60475-2 |
0.653 |
|
| 2011 |
Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World Journal of Gastroenterology : Wjg. 17: 3888-98. PMID 22025877 DOI: 10.3748/Wjg.V17.I34.3888 |
0.372 |
|
| 2011 |
Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflammatory Bowel Diseases. 17: 1651-64. PMID 21744421 DOI: 10.1002/Ibd.21538 |
0.521 |
|
| 2011 |
Bashashati M, Hu H, Keenan CM, Cravatt BF, Sharkey KA. N-Acylphosphatidylethanolamines as Novel Regulators of Gastrointestinal Motility in the Mouse Gastroenterology. 140: S-100. DOI: 10.1016/S0016-5085(11)60407-1 |
0.513 |
|
| 2010 |
Storr MA, Bashashati M, Hirota C, Vemuri VK, Keenan CM, Duncan M, Lutz B, Mackie K, Makriyannis A, Macnaughton WK, Sharkey KA. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22: 787-96, e223. PMID 20180825 DOI: 10.1111/J.1365-2982.2010.01478.X |
0.646 |
|
| 2010 |
Martin GR, Bashashati M, Keenan CM, MacNaughton WK, Jirik F, Sharkey KA. 724 The Functional Role of Cellular Prion Protein in the Enteric Nervous System Gastroenterology. 138: S-97. DOI: 10.1016/S0016-5085(10)60445-3 |
0.567 |
|
| 2009 |
Fichna J, Schicho R, Andrews CN, Bashashati M, Klompus M, McKay DM, Sharkey KA, Zjawiony JK, Janecka A, Storr MA. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 21: 1326-e128. PMID 19650775 DOI: 10.1111/J.1365-2982.2009.01369.X |
0.688 |
|
| 2009 |
Storr M, Bashashati M, Vemuri K, Alapafuja S, Ho W, Keenan CM, Kunos G, Makriyannis A, Davison JS, Sharkey KA. W1697 Regional Specificity of Fatty Acid Amide Hydrolase (FAAH) Inhibition On Contractility in the Mouse Intestine: Endotoxin Upregulation of Faah Sensitivity in the Ileum Gastroenterology. 136: A-719. DOI: 10.1016/S0016-5085(09)63320-5 |
0.616 |
|
| 2007 |
Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, Movahedi M, Fazlollahi MR, Zandieh F, Roohi Z, Abdollahzade S, Salavati A, Kouhi A, Talebpour B, Daryani NE. Gastrointestinal manifestations in patients with common variable immunodeficiency. Digestive Diseases and Sciences. 52: 2977-83. PMID 17431775 DOI: 10.1007/S10620-006-9736-6 |
0.305 |
|
| Show low-probability matches. |